Article
Author(s):
Top stories of the week on Specialty Pharmacy Times.
[<a href="//storify.com/pharmacytimes/pcsk9-approval-biosimilar-cost" target="_blank">View the story "New PCSK9 Approval, Biosimilar Cost Tops Specialty Pharmacy Week in Review" on Storify</a>]
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa